We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
New Hampshire’s Supreme Court ruled private attorneys can continue to represent the state in an investigation into the pharmaceutical industry. Read More
Teva Pharmaceuticals filed a federal lawsuit accusing a former executive of passing trade secrets to rival firm Apotex through her boyfriend, Apotex CEO Jeremy Desai. Read More
An FDA-requested report from the National Academies of Sciences, Engineering and Medicine said it is possible to slow the spread of the opioid epidemic without limiting access to properly prescribed painkillers. Read More
The settlement, the largest of its kind, also resolves claims that the company did not meet obligations to report suspicious orders of controlled substances. Read More
The FDA published new product-specific draft guidances for establishing bioequivalence in 20 drugs and combinations. The agency also revised draft guidances for 12 more substances. Read More
Congress is looking into making statutory changes to the way FDA governs off-label use of medical products and other pre- and postmarket communications between medical manufacturers, physicians and patients. Read More